119th Congress•House
HR. 2450
CommitteePrescription Drug Transparency and Affordability Act
Latest action
2025-03-27
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Key actions
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
Bill text versions
Related bills
- HR. 7148 (119) · Related billBecame Public Law No: 119-75.
- HR. 6703 (119) · Related billReceived in the Senate.
- S. 891 (119) · Related billRead twice and referred to the Committee on Finance.
- S. 891 (119) · Related billRead twice and referred to the Committee on Finance.
- HR. 1768 (119) · Related billReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- HR. 1768 (119) · Related billReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.